Charles Schwab’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.88M | Sell |
2,888,058
-747,468
| -21% | -$2.32M | ﹤0.01% | 2160 |
|
|
2026
Q1 | $8.29M | Sell |
3,635,526
-421,530
| -10% | -$971K | ﹤0.01% | 2191 |
|
|
2025
Q4 | $11.4M | Buy |
4,057,056
+848,141
| +26% | +$3.03M | ﹤0.01% | 2070 |
|
|
2025
Q3 | $15.4M | Buy |
3,208,915
+133,514
| +4% | +$849K | ﹤0.01% | 1888 |
|
|
2025
Q2 | $28M | Buy |
3,075,401
+322,441
| +12% | +$2.38M | ﹤0.01% | 1476 |
|
|
2025
Q1 | $24.9M | Buy |
2,752,960
+447,917
| +19% | +$4.73M | ﹤0.01% | 1511 |
|
|
2024
Q4 | $30.1M | Buy |
2,305,043
+276,807
| +14% | +$3.69M | 0.01% | 1456 |
|
|
2024
Q3 | $31.8M | Buy |
2,028,236
+187,079
| +10% | +$2.83M | 0.01% | 1424 |
|
|
2024
Q2 | $24.9M | Buy |
1,841,157
+83,833
| +5% | +$1.72M | ﹤0.01% | 1530 |
|
|
2024
Q1 | $48.7M | Buy |
1,757,324
+932,182
| +113% | +$20.7M | 0.01% | 1063 |
|
|
2023
Q4 | $15.9M | Buy |
825,142
+38,393
| +5% | +$695K | ﹤0.01% | 1725 |
|
|
2023
Q3 | $12.7M | Buy |
786,749
+59,128
| +8% | +$1.05M | ﹤0.01% | 1789 |
|
|
2023
Q2 | $13.9M | Buy |
727,621
+45,711
| +7% | +$815K | ﹤0.01% | 1738 |
|
|
2023
Q1 | $9.92M | Sell |
681,910
-391,122
| -36% | -$7.01M | ﹤0.01% | 1881 |
|
|
2022
Q4 | $21M | Buy |
1,073,032
+117,505
| +12% | +$2.29M | 0.01% | 1401 |
|
|
2022
Q3 | $23M | Buy |
955,527
+51,431
| +6% | +$1.58M | 0.01% | 1266 |
|
|
2022
Q2 | $28.4M | Buy |
904,096
+31,669
| +4% | +$1.15M | 0.01% | 1132 |
|
|
2022
Q1 | $38.4M | Buy |
872,427
+4,958
| +0.6% | +$213K | 0.01% | 1056 |
|
|
2021
Q4 | $37.7M | Sell |
867,469
-87,416
| -9% | -$3.43M | 0.01% | 1099 |
|
|
2021
Q3 | $29.9M | Sell |
954,885
-79,716
| -8% | -$3.14M | 0.01% | 1233 |
|
|
2021
Q2 | $43.8M | Sell |
1,034,601
-250,361
| -19% | -$9.74M | 0.01% | 966 |
|
|
2021
Q1 | $48.3M | Buy |
1,284,962
+586,476
| +84% | +$18.3M | 0.02% | 855 |
|
|
2020
Q4 | $18.9M | Sell |
698,486
-22,908
| -3% | -$589K | 0.01% | 1450 |
|
|
2020
Q3 | $18.1M | Sell |
721,394
-84,997
| -11% | -$1.24M | 0.01% | 1270 |
|
|
2020
Q2 | $6.14M | Buy |
806,391
+336,771
| +72% | +$2.46M | ﹤0.01% | 1922 |
|
|
2020
Q1 | $4.3M | Buy |
469,620
+94,677
| +25% | +$571K | ﹤0.01% | 1905 |
|
|
2019
Q4 | $1.94M | Buy |
374,943
+9,139
| +2% | +$58.7K | ﹤0.01% | 2430 |
|
|
2019
Q3 | $2.13M | Buy |
365,804
+34,966
| +11% | +$157K | ﹤0.01% | 2355 |
|
|
2019
Q2 | $1.06M | Sell |
330,838
-22,919
| -6% | -$78.2K | ﹤0.01% | 2556 |
|
|
2019
Q1 | $1.45M | Sell |
353,757
-234,847
| -40% | -$1.49M | ﹤0.01% | 2453 |
|
|
2018
Q4 | $3.73M | Buy |
588,604
+46,628
| +9% | +$484K | ﹤0.01% | 2054 |
|
|
2018
Q3 | $8.95M | Buy |
541,976
+49,365
| +10% | +$839K | 0.01% | 1715 |
|
|
2018
Q2 | $8.23M | Buy |
492,611
+59,394
| +14% | +$961K | 0.01% | 1722 |
|
|
2018
Q1 | $6.74M | Buy |
433,217
+55,731
| +15% | +$994K | 0.01% | 1779 |
|
|
2017
Q4 | $7.13M | Buy |
377,486
+7,054
| +2% | +$156K | 0.01% | 1706 |
|
|
2017
Q3 | $10.8M | Sell |
370,432
-3,142
| -0.8% | -$92.8K | 0.01% | 1368 |
|
|
2017
Q2 | $12M | Sell |
373,574
-14,930
| -4% | -$490K | 0.01% | 1222 |
|
|
2017
Q1 | $13.4M | Buy |
388,504
+39,292
| +11% | +$1.4M | 0.01% | 1097 |
|
|
2016
Q4 | $12.3M | Sell |
349,212
-14,590
| -4% | -$493K | 0.01% | 1102 |
|
|
2016
Q3 | $12.6M | Sell |
363,802
-22,393
| -6% | -$784K | 0.01% | 989 |
|
|
2016
Q2 | $14.4M | Buy |
386,195
+23,138
| +6% | +$870K | 0.02% | 836 |
|
|
2016
Q1 | $14.7M | Buy |
363,057
+13,744
| +4% | +$512K | 0.02% | 801 |
|
|
2015
Q4 | $12.6M | Sell |
349,313
-2,450
| -0.7% | -$88.6K | 0.02% | 875 |
|
|
2015
Q3 | $11.2M | Buy |
351,763
+94,821
| +37% | +$3.23M | 0.02% | 919 |
|
|
2015
Q2 | $8.74M | Buy |
256,942
+9,868
| +4% | +$332K | 0.01% | 1148 |
|
|
2015
Q1 | $8.36M | Sell |
247,074
-17,443
| -7% | -$608K | 0.01% | 1131 |
|
|
2014
Q4 | $9.29M | Buy |
264,517
+11,709
| +5% | +$394K | 0.01% | 947 |
|
|
2014
Q3 | $8.28M | Buy |
252,808
+16,035
| +7% | +$546K | 0.01% | 966 |
|
|
2014
Q2 | $8.05M | Buy |
236,773
+6,793
| +3% | +$233K | 0.01% | 1008 |
|
|
2014
Q1 | $8.06M | Buy |
229,980
+7,636
| +3% | +$269K | 0.01% | 960 |
|
|
2013
Q4 | $8.13M | Buy |
222,344
+12,380
| +6% | +$454K | 0.02% | 871 |
|
|
2013
Q3 | $7.28M | Sell |
209,964
-7,800
| -4% | -$273K | 0.01% | 861 |
|
|
2013
Q2 | $7.45M | Buy |
+217,764
| New | +$7.23M | 0.02% | 736 |
|
Other funds holding ACH
CCM
ICM
PCMI
DIA
Charles Schwab's ACH Position: Q2 2026 in Review
Charles Schwab reduced its Accendra Health (ACH) stake by 21% in Q2 2026, selling an estimated $2.32M and leaving 2,888,058 shares worth $9.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2160.
Charles Schwab first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $48.7M in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Charles Schwab held 2,888,058 shares of Accendra Health worth $9.88M as of Q2 2026.
- Charles Schwab sold 747,468 Accendra Health shares in Q2 2026, an estimated $2.32M.
- Accendra Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2160 holding.
- Charles Schwab first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Accendra Health position peaked at $48.7M in Q1 2024.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.